FDA: Mix-up Prompts Montelukast Sodium Tablet Recall – Drug for nerve pain boosts high for opioid abusers.

1968_Graphic Image_Standard_060115Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

FDA: Mix-up Prompts Montelukast Sodium Tablet Recall – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

One lot of Montelukast Sodium Tablets (MON17384, expiration 12/31/2019) is being voluntarily recalled by Camber Pharmaceuticals. In a warning to consumers and health care professionals, officials with the FDA said sealed bottles labeled as Camber’s allergy and asthma medication ‘montelukast sodium tablets, 10 milligram, 30-count’ were found to instead contain 90 tablets of Losartan Potassium Tablets, 50 mg. The tablet mix-up may pose a safety risk to consumers.

According to the FDA, patients taking losartan tablets when not prescribed this product are at risk for potential renal dysfunction, elevated potassium levels, and low blood pressure. These risks are especially high for a pregnant woman taking montelukast because losartan, which is indicated to treat high blood pressure, could harm or kill the fetus. The FDA is encouraging consumers who possess this recalled product to contact their health care provider or pharmacist immediately.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.